Facts & Figures

HIV

• As of December 31, 2024, the number of people diagnosed and living with HIV who reside in North Carolina (including those initially diagnosed in another state) was 38,614.
• In 2024, 1,391 people were newly diagnosed with HIV population, a rate of 15 per 100,000 adult and adolescent population (13 and older).
• The number of people newly categorized as having Stage 3 HIV (AIDS) increased post-pandemic. There was a 37% increase in people newly diagnosed with Stage 3 HIV (AIDS) in 2024 (N=699) compared to 2020 (N=510). This may be due to diagnoses delayed by the pandemic shutdown.
• There were 3 perinatal (mother-to-child) HIV transmissions documented in 2024.
• People aged 20 to 34 years old had the highest rates of newly diagnosed HIV in 2024 and comprised 55% (N=687; rate of 35 per 100,000) of the newly diagnosed population.
• Among race/ethnicity groups, Black/African Americans represented a majority (54%) of all adult/adolescents newly diagnosed with HIV in 2024, with a rate of 39 per 100,000 adult/adolescent population.
• Rates among Black/African men have been stable since 2022 (67 and 14 per 100,000 in 2024, respectively).
• The rate of newly diagnosed HIV increased among Hispanic/Latine people (30 per 100,000 in 2024 compared to 27 in 2023).

STD

• Chlamydia case numbers have remained steady since 2020 and slightly decreased in 2024; cases have not rebounded to pre-pandemic levels, possibly due in part to decreased testing. In 2024, there were 62,010 cases (rate of 572 cases per 100,000 population).
• Approximately 79% of chlamydia cases in 2024 were among persons aged 15-29 years.
• Gonorrhea cases have been declining since 2021; there were 22,255 gonorrhea cases in 2024 (rate of 205 cases per 100,000 population).
• Black/African American persons were more affected by gonorrhea, with 62% of gonorrhea cases in 2024 (13,810 cases; rate of 577 cases per 100,000 population); Black/African American persons had 9 times the rate of White persons (rate of 62 cases per 100,000 population).
• Early syphilis cases are more frequent among men, but declined in 2024 (2,649 cases in 2024, rate of 50 per 100,000), while early syphilis among women increased slightly in 2024 (964 cases in 2024, rate of 26 per 100,000). Early syphilis cases had increased steadily between 2012 and 2022, but have decreased slightly in 2024 driven by a decrease among men.
• Along with the continued increase of syphilis in women, congenital syphilis is increasing. There were 96 congenital syphilis cases in 2024 , including 6 stillbirths or neonatal deaths attributable to congenital syphilis; cases increased 200% compared to 2020.

Hepatitis B/C

• Acute hepatitis B case numbers peaked in 2018 and then declined. Acute hepatitis B cases increased in 2024; this may be due in part to the 2024 case definition change (see report for details). In 2024, there were 177 cases (rate of 2 per 100,000 population).
• More than two-thirds (69%) of acute hepatitis B cases in 2024 were among men.
• Reported chronic hepatitis B cases slightly decreased in 2024. In 2024, there were 1,119 chronic hepatitis B cases reported (rate of 10 cases per 100,000 population).
• Approximately 62% of chronic hepatitis B cases reported in 2024 were among persons aged 30-59 years.
• Acute hepatitis C cases declined 45% in 2024 compared to 2023; cases have not rebounded to pre-pandemic levels, possibly due to decreased testing. In 2024, there were 44 cases (rate of 0.4 cases per 100,000 population).
• More than half (59%) of acute hepatitis C cases in 2024 were among people aged 30-49 years.
• Reported chronic hepatitis C cases slightly decreased in 2024; cases have not rebounded to pre-pandemic levels, possibly due to decreased testing. In 2024, there were 8,966 chronic hepatitis C cases reported (rate of 83 cases per 100,000 population).
• Approximately 6 out of 10 of chronic hepatitis C cases (61%) reported in 2024 were among men.